The Role of CD56 NK Cells in Neurodegenerative Disorders

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2024 Feb 13

PMID 38350967

Authors

Carla Rodriguez-Mogeda

Chaja M J van Ansenwoude

Lennart van der Molen

Eva M M Strijbis

Reina E Mebius

Helga E de Vries

Affiliations

Soon will be listed here.

Abstract

Emerging evidence suggests a potential role for natural killer (NK) cells in neurodegenerative diseases, such as multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. However, the precise function of NK cells in these diseases remains ambiguous. The existence of two NK cell subsets, CD56 and CD56 NK cells, complicates the understanding of the contribution of NK cells in neurodegeneration as their functions within the context of neurodegenerative diseases may differ significantly. CD56 NK cells are potent cytokine secretors and are considered more immunoregulatory and less terminally differentiated than their mostly cytotoxic CD56 counterparts. Hence, this review focusses on NK cells, specifically on CD56 NK cells, and their role in neurodegenerative diseases. Moreover, it explores the mechanisms underlying their ability to enter the central nervous system. By consolidating current knowledge, we aim to provide a comprehensive overview on the role of CD56 NK cells in neurodegenerative diseases. Elucidating their impact on neurodegeneration may have implications for future therapeutic interventions, potentially ameliorating disease pathogenesis.

Citing Articles

Identifying high-risk candidates for prolonging progression-free survival in primary gastric carcinoma subject to "double invasion": an analytical approach utilizing lasso-cox regression.

Wang L, Chang Y, Ma J, Qu W, Li Y BMC Cancer. 2025; 25(1):381.

PMID: 40022037 PMC: 11871700. DOI: 10.1186/s12885-025-13810-z.

Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease.

Meng T, Zhang Y, Ye Y, Li H, He Y Eur J Med Res. 2025; 30(1):89.

PMID: 39920860 PMC: 11806906. DOI: 10.1186/s40001-025-02297-w.

Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis.

Alvarez-Sanchez E, Carbayo A, Valle-Tamayo N, Munoz L, Aumatell J, Torres S J Neuroinflammation. 2025; 22(1):15.

PMID: 39849490 PMC: 11756089. DOI: 10.1186/s12974-025-03347-0.

Immunomodulatory Effects of Modified Colostrum, Whey, and Their Combination With Other Natural Products: Effects on Natural Killer Cells.

Han X, Vollmer D, Yan X, Zhang Y, Zang M, Zhang C Curr Ther Res Clin Exp. 2024; 101:100750.

PMID: 39670221 PMC: 11637189. DOI: 10.1016/j.curtheres.2024.100750.

Role of Inflammation in the Development of COVID-19 to Parkinson's Disease.

Liu T, Wu H, Sun L, Wei J J Inflamm Res. 2024; 17:3259-3282.

PMID: 38800597 PMC: 11127656. DOI: 10.2147/JIR.S460161.

References

Kameritsch P, Renkawitz J . Principles of Leukocyte Migration Strategies. Trends Cell Biol. 2020; 30(10):818-832. DOI: 10.1016/j.tcb.2020.06.007. View

De Maria A, Bozzano F, Cantoni C, Moretta L . Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci U S A. 2010; 108(2):728-32. PMC: 3021076. DOI: 10.1073/pnas.1012356108. View

Brauning A, Rae M, Zhu G, Fulton E, Admasu T, Stolzing A . Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions. Cells. 2022; 11(6). PMC: 8947539. DOI: 10.3390/cells11061017. View

Lunemann A, Tackenberg B, DeAngelis T, Barreira da Silva R, Messmer B, Vanoaica L . Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis. Int Immunol. 2011; 23(2):139-48. PMC: 3030728. DOI: 10.1093/intimm/dxq463. View

Feldman E, Goutman S, Petri S, Mazzini L, Savelieff M, Shaw P . Amyotrophic lateral sclerosis. Lancet. 2022; 400(10360):1363-1380. PMC: 10089700. DOI: 10.1016/S0140-6736(22)01272-7. View

Martinez-Rodriguez J, Lopez-Botet M, Munteis E, Rio J, Roquer J, Montalban X . Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis. Clin Immunol. 2011; 141(3):348-56. DOI: 10.1016/j.clim.2011.09.006. View

Marsh S, Abud E, Lakatos A, Karimzadeh A, Yeung S, Davtyan H . The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A. 2016; 113(9):E1316-25. PMC: 4780638. DOI: 10.1073/pnas.1525466113. View

Fang T, Al Khleifat A, Meurgey J, Jones A, Leigh P, Bensimon G . Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018; 17(5):416-422. PMC: 5899963. DOI: 10.1016/S1474-4422(18)30054-1. View

Menees K, Lee J . New Insights and Implications of Natural Killer Cells in Parkinson's Disease. J Parkinsons Dis. 2022; 12(s1):S83-S92. PMC: 9535577. DOI: 10.3233/JPD-223212. View

10.

Perry J, Han S, Xu Q, Herman M, Kennedy L, Csako G . Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis. Sci Transl Med. 2012; 4(145):145ra106. PMC: 3846177. DOI: 10.1126/scitranslmed.3004140. View

11.

Yong V . Differential mechanisms of action of interferon-beta and glatiramer aetate in MS. Neurology. 2002; 59(6):802-8. DOI: 10.1212/wnl.59.6.802. View

12.

Mailliard R, Alber S, Shen H, Watkins S, Kirkwood J, Herberman R . IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med. 2005; 202(7):941-53. PMC: 2213172. DOI: 10.1084/jem.20050128. View

13.

Muller-Durovic B, Grahlert J, Devine O, Akbar A, Hess C . CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019; 11(2):724-740. PMC: 6366961. DOI: 10.18632/aging.101774. View

14.

Bhatnagar N, Ahmad F, Hong H, Eberhard J, Lu I, Ballmaier M . FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32). Eur J Immunol. 2014; 44(11):3368-79. DOI: 10.1002/eji.201444515. View

15.

Dobson R, Giovannoni G . Multiple sclerosis - a review. Eur J Neurol. 2018; 26(1):27-40. DOI: 10.1111/ene.13819. View

16.

Lyons A, Murphy K, Clarke R, Lynch M . Atorvastatin prevents age-related and amyloid-β-induced microglial activation by blocking interferon-γ release from natural killer cells in the brain. J Neuroinflammation. 2011; 8:27. PMC: 3077319. DOI: 10.1186/1742-2094-8-27. View

17.

Perera Molligoda Arachchige A . Human NK cells: From development to effector functions. Innate Immun. 2021; 27(3):212-229. PMC: 8054151. DOI: 10.1177/17534259211001512. View

18.

Leist T, Weissert R . Cladribine: mode of action and implications for treatment of multiple sclerosis. Clin Neuropharmacol. 2011; 34(1):28-35. DOI: 10.1097/WNF.0b013e318204cd90. View

19.

Jeong S, Shin D, Yoo T, Cho M, Jang W, Lee J . Association between statin use and Alzheimer's disease with dose response relationship. Sci Rep. 2021; 11(1):15280. PMC: 8316580. DOI: 10.1038/s41598-021-94803-3. View

20.

Vujanovic L, Chuckran C, Lin Y, Ding F, Sander C, Santos P . CD56 CD16 Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α. Front Immunol. 2019; 10:14. PMC: 6361792. DOI: 10.3389/fimmu.2019.00014. View